Evaluation of opioid receptor heterogeneity in isolated, field stimulated rat ileum
Liao, C.S.; Freer, R.J.
Proceedings of the Western Pharmacology Society 27: 439-442
1984
ISSN/ISBN: 0083-8969 PMID: 6093138 Document Number: 222519
Document emailed within 1 workday
Related Documents
van Vliet, B.J.; Mulder, A.H.; Schoffelmeer, A.N. 1990: Mu-opioid receptor-mediated inhibition of D-1 dopamine receptor stimulated adenylate cyclase in primary cultures of rat neostriatal neurons Progress in Clinical and Biological Research 328: 409-412Fang, L.; Knapp, R.J.; Horvath, R.; Matsunaga, T.O.; Haaseth, R.C.; Hruby, V.J.; Porreca, F.; Yamamura, H.I. 1994: Characterization of [3H]naltrindole binding to delta opioid receptors in mouse brain and mouse vas deferens: evidence for delta opioid receptor heterogeneity Journal of Pharmacology and Experimental Therapeutics 268(2): 836-846
Guimarães, C.L.; Rae, G.A. 1992: Dual effects of endothelins -1, -2 and -3 on guinea pig field-stimulated ileum: possible mediation by two receptors coupled to pertussis toxin-insensitive mechanisms Journal of Pharmacology and Experimental Therapeutics 261(3): 1253-1259
Gintzler, A.R.; Musacchio, J.M. 1975: Interactions of morphine, adenosine, adenosine triphosphate and phosphodiesterase inhibitors on the field-stimulated guinea-pig ileum Journal of Pharmacology and Experimental Therapeutics 194(3): 575-582
Spetea, M.; Asim, M.Faheem.; Noha, S.; Wolber, G.; Schmidhammer, H. 2013: Current κ opioid receptor ligands and discovery of a new molecular scaffold as a κ opioid receptor antagonist using pharmacophore-based virtual screening Current Pharmaceutical Design 19(42): 7362-7372
Re, G.; Belloli, C.; Badino, P.; Arioli, F.; Novelli, A.; Girardi, C.; Beretta, C. 1997: Identification of beta-adrenergic receptor subtypes mediating relaxation in isolated equine ileum American Journal of Veterinary Research 58(6): 621-625
Ochillo, R.F.; Tsai, C.S. 1988: A comparative study of the effects of aging on the responsiveness of the cholinergic receptor of the isolated ileum of mouse and rat Research Communications in Chemical Pathology and Pharmacology 60(2): 261-264
Endo, T.; Ogawa, T.; Hamaue, N.; Akita, K.; Hirafuji, M.; Minami, M.; Blower, P.R. 1998: Granisetron, a 5-HT3 receptor antagonist, inhibited cisplatin-induced 5-hydroxytryptamine release in the isolated ileum of ferrets Research Communications in Molecular Pathology and Pharmacology 100(3): 243-253
Endo, T.; Hamaue, N.; Ihira, E.; Teramoto, Y.; Liu, Y.; Hirafuji, M.; Minami, M. 2002: Effects of granisetron, a 5-HT3 receptor antagonist, on 5-hydroxytryptamine (5-HT) release from the isolated ileum in a delayed-emesis rat model Research Communications in Molecular Pathology and Pharmacology 111(1-4): 55-68
Carratù, M.R.; De Serio, A.; Lagioia, R.; Conte-Camerino, D.; Ferrari, E.; Mitolo-Chieppa, D. 1990: Effects of the partial dopamine receptor agonist, terguride, on the field-stimulated vas deferens in the mouse Bollettino della Societa Italiana di Biologia Sperimentale 66(1): 35-42
Endo, T.; Minami, M.; Kitamura, N.; Teramoto, Y.; Ogawa, T.; Nemoto, M.; Hamaue, N.; Hirafuji, M.; Yasuda, E.; Blower, P.R. 1999: Effects of various 5-HT3 receptor antagonists, granisetron, ondansetron, ramosetron and azasetron on serotonin (5-HT) release from the ferret isolated ileum Research Communications in Molecular Pathology and Pharmacology 104(2): 145-155
Seiler, S.M.; Peluso, M.; Tuttle, J.G.; Pryor, K.; Klimas, C.; Matsueda, G.R.; Bernatowicz, M.S. 1996: Thrombin receptor activation by thrombin and receptor-derived peptides in platelet and CHRF-288 cell membranes: receptor-stimulated GTPase and evaluation of agonists and partial agonists Molecular Pharmacology 49(1): 190-197
Baranowska, A.; Skowron, B.; Nowak, B.; Ciesielczyk, K.; Guzdek, P.; Gil, K.; Kaszuba-Zwoinska, J. 2017: Changes in viability of rat adipose-derived stem cells isolated from abdominal/perinuclear adipose tissue stimulated with pulsed electromagnetic field Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 68(2): 253-264
Balasiavichius, R.V.; Toleĭkis, A.I.; Prashkiavichius, A.K.; Iasaĭtis, A.A. 1985: Evaluation of structuro-functional heterogeneity of isolated mitochondria from the normal and the ischemic myocardium Biokhimiia 50(10): 1685-1693
Zimmerman, D.M.; Leander, J.D.; Reel, J.K.; Hynes, M.D. 1987: Use of beta-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands Journal of Pharmacology and Experimental Therapeutics 241(2): 374-378
Ray, S.B.; Gupta, Y.K.; Wadhwa, S. 2005: Expression of opioid receptor-like 1 (ORL1) and mu opioid receptors in the spinal cord of morphine tolerant mice Indian Journal of Medical Research 121(3): 194-202
Cserpán, E.; Tryoen-Tóth, P.; Bajenaru, L.; Benyhe, S.; Maderspach, K. 1997: Differential expression of the K-2 opioid receptor protein under the effect of opioid agonists in embryonic chick neurons in vitro Neurobiology 5(2): 233-248
Musacchio, J.M.; Puig, M.M.; Casper, M.; Nodar, R. 1980: Opioid peptides in the guinea pig ileum Advances in Biochemical Psychopharmacology 22: 313-321
Mosberg, H.I.; Heyl, D.L.; Haaseth, R.C.; Omnaas, J.R.; Medzihradsky, F.; Smith, C.B. 1990: Cyclic dermorphin-like tetrapeptides with delta-opioid receptor selectivity. 3. Effect of residue 3 modification on in vitro opioid activity Molecular Pharmacology 38(6): 924-928
Kaneto, H.; Watanabe, J. 1980: Tolerance to and dependence on opioids in isolated longitudinal muscle of guinea pig ileum. Validity of the muscle preparation as a receptor model for opioids Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 76(5): 347-354